Introduction {#Sec1}
============

Myelokathexis was introduced by Zeulzer \[[@CR22]\] to describe a new form of chronic granulocytopenia characterized by an excessive bone marrow retention of peculiar senescent granulocytes with hypersegmented nuclear lobes. Later, the WHIM acronym was used to describe patients with viral warts, hypogammaglobulinemia, infections, and myelokathexis \[[@CR20]\]. Patients with WHIM syndrome demonstrate a significant variability of clinical symptoms \[[@CR5]\]. Typically, severe non-cyclic neutropenia without an increase in neutrophil count during infections is observed \[[@CR12], [@CR13]\]. Quantitative and qualitative leukocyte abnormalities also affect lymphocytes, with a reduction in circulating naive T cells and memory B cells along with an increase in effector T cells \[[@CR6]\]. Moreover, lymphopenia is observed and the low level of immunoglobulins implicates dysfunction of B cells \[[@CR4]\]. Patients suffer from recurrent bacterial infections affecting mainly the respiratory tract, skin, middle ear, and gingiva which respond to antibiotic therapy. The skin symptoms include human papilloma virusinduced viral warts and erosions in the perianal region which are resistant to therapy \[[@CR5]\]. Epstein-Barr virusrelated B-cell lymphomas were described in two patients \[[@CR3], [@CR9]\] and one patient with Kaposi sarcoma was reported, which may suggest an increased risk of lymphoid malignancies in WHIM syndrome, possibly induced by Herpes viruses \[[@CR3]\].

Family studies imply an autosomal-dominant inheritance, while only one family was described with an apparent autosomal-recessive mode, explained by a paternal mosaicism \[[@CR7]\]. The sporadic cases are rare and have so far been described mostly in women \[[@CR19]\]. The identification of 23 candidate genes was based on whole autosome scans in three families with WHIM syndrome \[[@CR7]\]. Mutations of the chemokine receptor *CXCR4* family gene were finally recognized in pivotal association with this syndrome. Interactions between CXCR4 and its ligand CXCL12 (stromal-derived factor 1) are crucial for fetal hematopoiesis and the trafficking of hematopoietic cells \[[@CR11], [@CR16], [@CR17]\]. All known *CXCR4* mutations responsible for the WHIM phenotype are heterozygous and affect the C-terminal cytoplasmic tail of the protein with its truncation \[[@CR6], [@CR7], [@CR17]\]. Subsequently, T lymphocytes and mature granulocytes of WHIM patients were shown to manifest an enhanced chemotactic response to CXCL12, which may explain the trapping of mature and senescent neutrophils within bone marrow and enhanced removal of mature granulocytes from the circulation \[[@CR6]\]. The most frequent 1000 C→T mutation within the second *CXCR4* exon leads to altered receptor internalization and surface recovery pathways \[[@CR10]\]. However, the exact mechanisms linking the profound abnormalities in CXCR4-CXCL12 signaling and the WHIM phenotype are not entirely clear. Moreover, in some WHIM patients a *CXCR4* mutation was excluded by sequencing the whole gene \[[@CR2], [@CR7]\].

The present report describes a sporadic case of WHIM in a woman and the perinatal diagnosis of WHIM syndrome in her two newborn sons. This sporadic case was proved by *CXCR4* gene sequencing and forensic analysis of the appropriate family short tandem repeats (STRs) in three generations (grandparents, mother and sons). The affected children were first diagnosed by genetic analysis of cord blood cells. Because of the profound monocytopenia seen in the mother and her first son, two main subpopulations of monocytes, "classical" (CD14^++^CD16^−^) and "proinflammatory" (CD14^+^CD16^+^), were also analyzed.

Case Presentation {#Sec2}
=================

A 23-year-old woman was referred to the hospital for complex immunological tests with an initial diagnosis of common variable immunodeficiency (CVID) because of hypogammaglobulinemia. She had been suffering since childhood from recurrent sino-pulmonary infections; first pneumonia occurred in the second month of life with a white blood cell count of 0.3×10^9^/l. Leukopenia (0.86×10^9^/l) was noted again during the course of pneumonia at the age of 9 years. Upon diagnosing a non-cyclic leukopenia, therapy with subcutaneous (s.c.) GM-CSF or G-CSF was started. During the previous 5 years she was treated with antibiotics because of acute or exacerbant sinusitis and/or pneumonia. Vaginal, but not skin, warts were observed when she was 20 years old. The family history was negative; her parents, seven siblings, and other known relatives were free of significant infections or warts.

On admission she was in good condition, with a mild sinusitis. She responded poorly to antibiotics and G-CSF therapy. Two trephine bone marrow biopsies were performed, but the material was unsatisfactory to make a diagnosis. The results of laboratory tests on admission are shown in Table [1](#Tab1){ref-type="table"}. Blood biochemistry and coagulation were within normal ranges. There were no symptoms of autoimmune disease and autoantibodies were absent. Ultasonography showed a slight splenomegaly and X-ray and CT scans revealed bilateral shading of the maxillary and frontal sinuses. The clinical history, present symptoms, and an immunological workup suggested a diagnosis of CVID. The therapy included intravenous immunoglobulin substitution with an initial dose of 0.6 g/kg b.w. i.v. every 10 days followed by three infusions of 0.4 g/kg every four weeks and G-CSF therapy (5 µg/kg s.c. every second day). During the two-year therapy, pulmonary infections became less frequent. After 18 months of treatment, the next trephine bone marrow biopsy was performed. The morphological changes in the bone marrow were typical (see below) and WHIM syndrome was suspected. The diagnosis was confirmed by DNA sequencing. Table 1The results of immunological tests in mother and her children with WHIM syndromeTestsMotherBoy 1 at 8 months of lifeBoy 2 at 4 months of lifetests resultsnormal rangetests resultsnormal rangetests resultsnormal rangeGranulocyte count (×10^9^/l)0.172 (17.2% of normal value)1.00--5.000.03 (3.0% of normal value)1.00--8.000.031 (4.41% of normal value)0.70--4.8Lymphocyte count (×10^9^/l)0.662 (66% of normal value)1.00--4.002.0 (58.8% of normal value)3.40--10.502.852 (86.4% of normal value)3.30--10.3Immunoglobulin level:IgG\* g/l4.307.00--16.001.672.76--7.442.502.66--7.01IgA g/l0.370.67--3.67\<0.060.13--0.810.070.07--0.37IgM g/l0.380.41--2.030.170.26--1.340.410.17--0.86Lymphocytes:B lymphocytes (CD19/µl)9110--57080610--26006135--2000T lymphocytesCD3 (/µl)1711000--220017001900--590010532500--5500CD4 (/µl)57530--130013201400--43008061600--4000CD8 (/µl)93330--920320500--1700221560--1700NK (CD3^−^, CD16^+^/CD56^+^) (/µl)10570--480180160--9501431702-1100Lymphoproliferationanti-CD3 (SI)1\>152\>1592\>15PHA (SI)1\>151\>1592\>15\*Before IVIG therapy.Abbreviations: SI --- stimulation index, PHA --- phytohemagglutinin.

After two years of therapy she became pregnant. The IVIG therapy was continued with a dosage of 0.6 g/kg b.w. every three weeks, G-CSF was discontinued, and no complications were observed during pregnancy. The child was delivered by caesarian section at the 41st week of pregnancy. Cord blood was taken for assessment of the *CXCR4* gene sequence. The boy had a birth-weight of 2980 g and 8 points on the Apgar scale. No infections were recorded in the neonatal period. DNA sequencing studies showed a mutation similar to that found in the mother. On the 14th day of life he was admitted to the local hospital because of leukopenia, but neither G-CSF therapy was introduce nor immunological tests performed. At the age of 8 months, blood was taken for genetic and immunological tests (Table [1](#Tab1){ref-type="table"}). The initial diagnosis of WHIM based on a cord blood assay was confirmed by sequencing *CXCR4*-DNA isolated from peripheral blood mononuclear cells. His general condition was good, his weight within the normal range for this age. A flat angioma of the occipital region was noted. The therapy included G-CSF (5 µg/kg s.c.) and IVIG substitution (an initial dose of 0.25 g/kg b.w. followed by 0.5 g/kg b.w.) from the 8th month of life. At the age of 11 months he suffered from pneumonia with severe bronchospasms. The treatment with adrenalin, β2 mimetics by inhalation, antibiotics, and steroids i.v. was effective. Since then the boy remains healthy under constant antiallergic therapy with preventive antibiotics, G-CSF administered every 48 h, and IVIG every four weeks.

The second boy was born with a weight of 2800 g and 9 points on the Apgar scale six months ago. The tests using cord and peripheral blood (in the fourth month of life) showed a mutation, identical to that of his mother, of the *CXCR4* gene and pronounced granulocytopenia since birth. He is in good condition and on G-CSF and IVIG (since the fourth month of life) therapy.

The presented children developed severe neutropenia as the first symptom of WHIM syndrome. The hypogammaglobulinemia was mild due to regular substitution of the mother during pregnancy. The appropriate substitution with IVIG is believed to prevent or diminish the severity of common infections; therefore the early diagnosis of the children allowed treatment according to the gradual development of clinical symptoms of WHIM syndrome. The first child received IVIG from the eighth month of life, but despite this he developed severe pneumonia at the age of 11 months. After that there were no serious infections despite persistent neutropenia. It seems that IVIG substitution therapy might have been introduced too late in this case. Therefore, IVIG preparations were introduced in the second son in the fourth month of life and until now (the sixth month) he has not had severe infections. Nevertheless, IVIG may not completely prevent, but only significantly reduce, the incidence of respiratory tract infections in immunodeficient children, as was already shown in common variable immunodeficient patients \[[@CR14]\].

Materials and Methods {#Sec3}
=====================

Tissue samples {#Sec4}
--------------

The blood and bone marrow samples from the mother and blood samples from her parents were analyzed. Cord and peripheral blood from the newborns was also studied. Trephine bone marrow biopsies obtained from the superior/inferior iliac crest of the mother using Jamshidi needles were routinely fixed in buffered formalin, decalcified in acid-based medium (Shandon TBD-1™ Decalcifier, Thermo Electronic Corporation, Runcorn, UK), embedded in paraffin, and cut into 3- to 4-µm sections. The sections were stained with hematoxylin and eosin (H&E), Gomori silver, Giemsa, and PAS methods. Bone marrow and peripheral blood smears were routinely stained with May-Grunwald-Giemsa. The parents and grandparents gave informed consent to participate in the study, which was also approved by the ethics review board of the Jagiellonian University Medical College (permission No. KBET/107//B/2006).

Sequencing the CXCR4 gene {#Sec5}
-------------------------

Both exons of the *CXCR4* gene were sequenced to look for mutations typical of WHIM syndrome. DNA was extracted with a QIAmp DNA Mini Kit (Qiagen, Germany) according to the manufacturer's instructions. PCR has been performed in a total volume of 20 ml, with 100 ng of spectrophotometrically quantified DNA, 0.5 U of DNA polymerase (Promega, WI, USA), 1.5 mM MgCl~2~, 200 µM dNTP, and 0.5 µM of primers specific to the second exon of the *CXCR4* gene (sense: 5′-TCC TCA TCC TGG CTT TCT TC, antisense: 5′-GCA TAA ACA GCT GGG GAT CA). The PCR cycles were 1 min. at 95°C followed by 35 amplification cycles (95°C for 45 s, 65°C for 45 s, 72°C for 1 min) and final incubation at 4°C until the analysis commenced. The PCR products were purified with a QIAquick Gel Extraction Kit (Qiagen).

Sequencing PCR was performed on the PCR products with using fluorescently labeled nucleotides (Big Dye Terminator v3.1 Cycle Sequencing Kit, Applied Biosystems, CA, USA) and exon-specific primers. The PCR reaction parameters were as follows: reaction mix --- 10 ng DNA mixed with 8 µl Terminator Ready Reaction Mix, 3.2 pM of each primer in a final volume of 20 µl, PCR cycles --- 1 min at 96°C followed by 25 amplification cycles (96°C for 10 s, 50°C for 5 s, 60°C for 4 min) and held at 4°C for purification.

The PCR products were purified by ethanol/EDTA precipitation. The PCR products were dissolved in 25 µl of Template Suppression Reagent (Applied Biosystems), denatured, and run on the Applied Biosystems 310 sequencing apparatus and analyzed with the Sequencing Analysis software (Applied Biosystems).

PCR-STR forensic analysis: family study {#Sec6}
---------------------------------------

DNA was extracted from fresh whole blood of the mother (WHIM syndrome) and her parents, as described above. The test was performed with an AmpFlSTR SGM Plus PCR Amplification Kit (Applied Biosystems). PCR was performed using fluorescently labeled primers. PCR reaction: 21 µl AmpFlSTR PCR Reaction Mix, 1 µl polymerase Ampli Gold, 11 µl AmpFlSTR SGM Plus Primer Set, and 1--2.5 ng DNA. The cycling conditions were 95°C for 11 min, 94°C for 1 min, 59°C for 1 min, 72°C for 1 min for 28 cycles, 60°C for 45 min, and final incubation at 25°C until ready for the analysis. The fluorescently labeled PCR products were run on the Applied Biosystems 310 sequencing apparatus and analyzed with 310 GeneScan3.1.2 software.

Monocyte staining and analysis {#Sec7}
------------------------------

The patients' blood samples (200 µl) were washed with 3 ml of 0.9% NaCl in polypropylene round-bottom tubes (Falcon, Becton Dickinson Biosciences//Pharmingen: BD, Belgium) and 100 µl of the 200 µl of cell suspension left after centrifugation was put into a TruCount Tube with microbeads (BD). Then the cells were stained on ice for 30 min with 5 µl of anti-CD45-APC (\#340910, clone 2D1; BD), -HLA-DR-PerCP (\#347402, clone L243; BD), -CD14-FITC (\#6603511, clone MY4, Beckman-Coulter, Ireland), and -CD16-PE (\#332779, clone Leu11c; BD) monoclonal antibodies. The samples were then treated with 400 µl of FACS Lysing Solution (BD) for 3-5 min until erythrocytes were lysed and the cells were immediately acquired on a FACSCanto (BD) flow cytometer along with 10,000 beads, then analyzed with FACSDiva Software (BD, CA, USA). The absolute numbers of CD14^+^CD16^+^ and CD14^++^CD16^−^ monocytes were calculated based on the acquired bead count (10,000 in each sample) according to the manufacturer\'s instructions.

Results {#Sec8}
=======

Bone marrow morphology {#Sec9}
----------------------

The bone marrow of the mother showed high cellularity with an excess of myeloid cells, mostly hypersegmented (senescent) neutrophils (Fig. [1](#Fig1){ref-type="fig"}). A uniform but very narrow paratrabecular rim of promyelocytes was present. Normal topography and undisturbed maturation pattern of erythroid cells and megakaryocytes were noted. There was no increase in lymphoid cells, mast cells, or blasts. Also, minimal widespread reticulin fibrosis and distended blood vessels were seen. Bone marrow and peripheral blood smears confirmed the characteristic abnormalities of granulocytes, with a marked nuclear hypersegmentation, thin and long chromatin filaments connecting the nuclear lobes, and abnormal variability in nuclear lobe sizes. Fig. 1Highly cellular bone marrow biopsy of the WHIM-mother, with increased mature neutrophil granulocytes showing prominent nuclear segmentation. Inset: bone marrow smear reveals abnormal nuclear segmentation patterns, including variability in nuclear lobe sizes and unusually slender chromatin filaments connecting the nuclear lobes.

Genetic studies {#Sec10}
---------------

No mutations on the first exon of the *CXCR4* gene were found. The studies concentrated on mutations on the second exon associated with changes in the intracellular tail domain essential for CXCR4 protein internalization \[[@CR7]\]. The only observed change was C→T heterozygosity at the base corresponding to position 1000 in the *CXCR4*-DNA second exon sequence leading to a TGA stop codon. The observed nonsense mutation may cause shortening of the cytoplasmatic tail of CXCR4 protein. Such mutations were observed in the mother and in both her sons in the cells taken from cord and peripheral blood (Fig. [2](#Fig2){ref-type="fig"}). No such changes were found in the grandparents (data not shown). Neither the previously described \[[@CR7]\] deletion of CT dinucleotide at position 1016--1017 nor a G→T change at position 1027 were found in the cDNA sequences. Forensic analysis of all 11 tested STR loci of the mother's DNA revealed alleles specific to her parents, corroborating the notion of the spontaneous character of *CXCR4* mutation in the mother, which had occurred in chromosome 2 of one of the parents of the proposita.

Immunological tests {#Sec11}
-------------------

The immunological tests showed a lowered level of immunoglobulins of all classes in the mother and both her sons (apart from IgM in the second son) and markedly lowered absolute numbers of B (CD19^+^) lymphocytes in the mother and first son. Low numbers of T lymphocytes in the mother and an inverse ratio of CD4:CD8 were noted. Borderline numbers of T lymphocytes were observed in the children. There were no responses to mitogen and CD3 stimulation in the mother and first son (Table [1](#Tab1){ref-type="table"}). Fig. 2Electropherograms of a portion of the *CXCR4* gene\'s second exon of the mother and her children with WHIM syndrome show C→T heterozygosity at position 1000 in the cDNA sequence. Cord blood and peripheral blood collected from the children in the eighth (first son) and fourth (second son) months of life were taken for the study.

A low number of "proinflammatory" CD14^+^CD16^+^ monocytes in the mother (1 cell/µl; Fig. [3C](#Fig3){ref-type="fig"}) and in the first son (10 cells/µl; Fig. [3E](#Fig3){ref-type="fig"}) was also observed. The numbers of "classical" CD14^++^CD16^−^ monocytes were also decreased in both patients (59 cells/µl and 110 cells/µl, respectively; Figs. [3C](#Fig3){ref-type="fig"}, [E](#Fig3){ref-type="fig"}). In our material the numbers of CD14^+^CD16^+^ monocytes in healthy adult volunteers (over 18 years old) were 66±31 cells/µl (n=17) and in children 58±34 cells/µl (n=60). The numbers of CD14^++^CD16^−^ monocytes were, respectively, 549±233 cells/µl and 430±158 cells/µl. The plots in Figs. [3B](#Fig3){ref-type="fig"} and [3D](#Fig3){ref-type="fig"} are representative of age-matched blood donors without immunodeficiency. Fig. 3Analysis of the CD14^+^CD16^+^ and CD14^++^CD16^−^ subpopulations of monocytes. The gate was first set on a "CD45 vs. Side Scatter" dot plot around the CD45-positive monocytes and adjacent lymphocytes (data not shown). These cells were then gated to exclude the CD14-HLA-DR^−^ NK cell population (**A**) and finally analyzed with respect to CD14 and CD16 antigen expression (**B**). Analyses of a typical healthy adult (**B**) and healthy child (**D**) as well as the mother with WHIM syndrome (**C**) and her first son (**E**) are shown.

Discussion {#Sec12}
==========

The clinical and laboratory findings of WHIM syndrome are very typical; however, in practice the correct diagnosis may be delayed due to the rarity of the disease. In keeping with this, the reported case of sporadic WHIM syndrome was not definitely diagnosed in the mother until the age of 23 years, although the first symptoms occurred in the early childhood. The initial diagnosis of CVID was corrected after bone marrow examination, when hypercellularity with senescent granulocytes was noted. Although the clinical course was mild, the response to antibiotic therapy was limited. IVIG substitution resulted in a decrease in the frequency of infections. The response to G-CSF was rather poor; neutropenia was observed, but it seemed clinically silent. The mechanism of mobilization of neutrophil release from the bone marrow via desensitization of CXCR2 and increased signaling through the mutated CXCR4 by the pathogen might be the explanation \[[@CR4]\]. The sons, born with proper weights and without symptoms of the disease, were diagnosed with WHIM syndrome based on DNA sequencing of cord blood cells and the presence of the mutation identical to that observed in the mother. Although neutropenia was observed, the first serious infection occurred in first son at 11 months of life, despite IVIG substitution and GCSF therapy.

Myelokathexis is a morphological phenomenon highly suggestive of WHIM syndrome, but it is probably not entirely specific to this disease \[[@CR15], [@CR18]\]. A bone marrow examination of the mother revealed a limited response to G-CSF (inadequate promyelocyte mobilization), which is observed in patients with WHIM syndrome. The results of our study suggest that the defect in granulocyte function in WHIM is not limited to the postulated accumulation of senescent granulocytes in the bone marrow, but may also affect their development and maturation as well as the development and function of T and B cells (low levels of lymphocytes and immunoglobulins; Table [1](#Tab1){ref-type="table"}) and perhaps monocytes. The numbers of "proinflammatory" CD14^+^CD16^+^ monocytes \[[@CR20]\] and, to a lesser extent, "classical" CD14^++^CD16^−^ monocytes were significantly diminished in the peripheral blood of the mother and her first son in comparison with age-matched controls (Fig. [3B](#Fig3){ref-type="fig"}--[E](#Fig3){ref-type="fig"}). The expression of CXCR4 molecule was higher on monocytes obtained from WHIM patients than on those from healthy persons (data not shown). This might be associated with disturbed chemothaxis of monocytes and/or granulocytes from niches with a high concentration of CXCL12 in the bone marrow as well as macrophages in tissues. Together this suggests that the proinflammatory response of macrophages, as well as antigen presentation, may not be as effective as in healthy individuals. Therefore, GM-CSF and/or IFN-γ herapy may be superior to G-CSF substitution in patients refractory to this cytokine, but this requires additional studies.

The preference to female gender is characteristic of the sporadic form of WHIM \[[@CR1], [@CR4], [@CR8], [@CR19]\]. The clinical course is rather mild and neutropenia is the main recognized and diagnosed symptom. The rarity of WHIM syndrome and the clinical variations in the combinations of symptoms (e.g. warts observed in the second decade and absent in children) are associated with the delay in the correct diagnosis. The possibility of infection-derived mobilization of neutrophils and good response to G-CSF and antibiotics in the majority of patients prevents a life-threatening course of infections. Women with WHIM syndrome may have normal pregnancy and delivery, but whether the children are affected depends on the type of heredity of WHIM syndrome.

To summarize, we have presented a case of sporadic WHIM syndrome in a young woman whose both sons also turned out to have inherited the same mutation. The diagnosis was made in the perinatal period by genetic analysis of the *CXCR4* gene in cord blood cells. Despite significant progress in genetics and pathophysiology, the diagnosis of WHIM may still depend on careful observation of cytological features of defective hematopoiesis in patients with clinical symptoms of immunodeficiency with neutropenia. It is suggested that perinatal diagnostics of WHIM syndrome based on a molecular DNA analysis of cord blood cells should be performed in cases of pregnancy of affected mothers.
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